Victory Capital Management Portfolio holdings
AUM
$155B
1-Year Return
20.6%
This Quarter Return
+10.16%
1 Year Return
+20.6%
3 Year Return
+77.5%
5 Year Return
+161.59%
10 Year Return
+412.71%
AUM
$102B
AUM Growth
+$7.37B
(+7.8%)
Cap. Flow
-$1.9B
Cap. Flow
% of AUM
-1.85%
Top 10 Holdings %
Top 10 Hldgs %
12.31%
Holding
2,628
New
89
Increased
1,115
Reduced
1,182
Closed
155
Top Buys
| 1 |
Target
TGT
|
+$562M |
| 2 |
Baker Hughes
BKR
|
+$451M |
| 3 |
eBay
EBAY
|
+$340M |
| 4 |
Regal Rexnord
RRX
|
+$224M |
| 5 |
Fidelity National Financial
FNF
|
+$174M |
Top Sells
| 1 |
Western Digital
WDC
|
+$385M |
| 2 |
Dick's Sporting Goods
DKS
|
+$314M |
| 3 |
HES
Hess
HES
|
+$288M |
| 4 |
Progressive
PGR
|
+$278M |
| 5 |
Sysco
SYY
|
+$234M |
Sector Composition
| 1 | Technology | 18.95% |
| 2 | Industrials | 13.53% |
| 3 | Financials | 12.85% |
| 4 | Consumer Discretionary | 11.29% |
| 5 | Healthcare | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Applied Digital
APLD
$4.45B
| $48.6K | ﹤0.01% |
+11,358
| New | +$48.6K |
|
2352
Taysha Gene Therapies
TSHA
$887M
| $48.6K | ﹤0.01% |
16,918
+1,318
| +8% | +$3.78K |
|
2353
American Vanguard Corp
AVD
$152M
| $47.8K | ﹤0.01% |
+3,692
| New | +$47.8K |
|
2354
Microvision
MVIS
$334M
| $46.8K | ﹤0.01% |
25,444
+89
| +0.4% | +$164 |
|
2355
DocGo
DCGO
$148M
| $46.2K | ﹤0.01% |
11,444
-347
| -3% | -$1.4K |
|
|
NXDR
2356
Nextdoor Holdings
NXDR
$771M
| $45.9K | ﹤0.01% |
20,389
+623
| +3% | +$1.4K |
|
2357
Cerus
CERS
$226M
| $43.6K | ﹤0.01% |
23,054
-533
| -2% | -$1.01K |
|
2358
CoreCard
CCRD
$208M
| $43K | ﹤0.01% |
3,894
-874
| -18% | -$9.66K |
|
2359
AST SpaceMobile
ASTS
$10.1B
| $42.7K | ﹤0.01% |
14,728
+4,030
| +38% | +$11.7K |
|
2360
Destination XL Group
DXLG
$67.9M
| $42.5K | ﹤0.01% |
+11,792
| New | +$42.5K |
|
2361
Petco
WOOF
$1B
| $42.2K | ﹤0.01% |
18,527
-1,728
| -9% | -$3.94K |
|
2362
Stem
STEM
$111M
| $42.2K | ﹤0.01% |
964
-13
| -1% | -$569 |
|
2363
The RealReal
REAL
$1.02B
| $42K | ﹤0.01% |
10,734
-225
| -2% | -$880 |
|
2364
Akebia Therapeutics
AKBA
$777M
| $39.9K | ﹤0.01% |
21,817
-702
| -3% | -$1.29K |
|
2365
Gannett
GCI
$601M
| $39.6K | ﹤0.01% |
16,225
-811
| -5% | -$1.98K |
|
2366
Clover Health Investments
CLOV
$1.55B
| $38.6K | ﹤0.01% |
48,657
-1,314
| -3% | -$1.04K |
|
2367
Amylyx Pharmaceuticals
AMLX
$1.05B
| $38.4K | ﹤0.01% |
+13,514
| New | +$38.4K |
|
2368
Xeris Biopharma Holdings
XERS
$1.26B
| $38.4K | ﹤0.01% |
17,355
-99
| -0.6% | -$219 |
|
2369
Lineage Cell Therapeutics
LCTX
$276M
| $36.5K | ﹤0.01% |
24,670
+1,175
| +5% | +$1.74K |
|
2370
Solid Power
SLDP
$645M
| $35.7K | ﹤0.01% |
17,606
-372
| -2% | -$755 |
|
2371
Renovaro
RENB
$47.8M
| $35.5K | ﹤0.01% |
+13,378
| New | +$35.5K |
|
2372
CommScope
COMM
$3.59B
| $35.4K | ﹤0.01% |
27,010
-558
| -2% | -$731 |
|
2373
GoPro
GPRO
$258M
| $35.3K | ﹤0.01% |
15,821
-658
| -4% | -$1.47K |
|
2374
SES AI
SES
$410M
| $35.3K | ﹤0.01% |
21,000
-1,663
| -7% | -$2.79K |
|
2375
SelectQuote
SLQT
$339M
| $35.2K | ﹤0.01% |
17,614
-248
| -1% | -$496 |
|